Perbedaan Efek Pemberian Asam Asetilsalisilat Dosis100 mg Dan 300 mg Terhadap Fungsi Aggregasi Trombosit, Kadar D-dimer Dan Outcome Fungsional Pada Penderita Stroke Iskemik Akut
DAFTAR PUSTAKA
Allen, L.M., Hasso, A.N., Handwerker, J., Fsrid, H. 2012. Sequencespesific MR Imaging Findings That Are Useful in Dating Ischemic
Stroke. Radiographics.32:1285-1297
An, G.H., Sim, S.Y., Jwa, C.S., Kim, G.H., Lee, J.Y., Kang, J.K. 2011.
Thromboxan A2 sinthetase inhibitor plus low dose aspirin : can it be
a salvage treatment in acute stroke beyond thrombolytic time
window.JJ Korean Neurosurg.50:1-2
Antiplatelet Trialists’ Collaboration. 2002. Collaborative overview of
randomised trials of antiplatelet therapy-I: prevention of death.
myocardial infarction. and stroke by prolonged antiplatelet therapy
in various categories of patients.BMJ.324:71–86
Arazi, H.C., Carnevalini, M., Falconi, E., Ovejero, R., Giorgi, M., Caroli, C.,
et al. 2012. The association of antiplateet aggregation effect of
aspirin and platelet count. Possible dosage implications.Rev Argent
Cardiol.80:114-120
Aydinalp, A., Atar, I., Altin, C., Gulmez, O., Atar, A., Acikel, S., et al. 2010.
Platelet function analysis with two different doses of aspirin. Ark
Turk Soc Cardiol.38(4):239-243
Bellomo, R., Ronco, C., Kellum, J.A., Mehta, R.L.,Palevsky, P.2004.Acute
renal failure-definition, outcome measures, animal models, fluid
therapy and information technology needs: the Second International
Consensus Confrence of the acute dialysis quality initiative (ADQI)
group. Crit Care.8(4)::204-212
Barber, M., Langhorne, P., Rumley, A., Lowe, G.D.O., Stott, D. 2006. DDimer Predicts Early Clinical Progression in Ischemic
Stroke.Stroke.37:1113-1115
Brass, L. 2010. Understanding and evaluating platelet function.American
Society of Hematology: 387-396
Cassar, K., Bachoo, P., Ford, I., Greaves, M., Brittenden, J. 2005.
Clopidogrel has no effect on D-dimer and thrombin-antithrombin III
levels in patients with peripheral arterial disease undergoing
peripheral percutaneous transluminal angioplasty. J Vasc
Surg.42:252-258
Chylova, M., Mot’ovska, Z., Osmancik, P., Prochazka, B., Kalvach, P.
2014. The effect of different doses and different routes of
acetylsalicylic acid administration on platelet aggregation in
healthy volunteers and ischemic stroke patients.Transl.Stroke
Res.6:160-165
Dahlan, M.S.2010. Besar sampel dan cara pengambilsan sampel dalam
penelitian kesehatan.Salemba Medika.Jakarta.Hal.46-60
Danesh, J., Whincup, P., Walker, M., Lennon, L., Thomson, A., Appleby,
P., et al. 2001. Fibrin D-dimer and coronary heart
disease.Circulation.103:2323-2327
DiChiara, J., Bliden, K.P., Tantry, U.S., Hamed, M.S., Antonino, M.J.,
Suarez, T.A., et al. 2007. The effect of aspirin dosing on platelet
function in diabetic and nondiabetic patients: An analysis from the
aspirin-induced platelet effect (ASPECT) Study.Diabetes.56:30143019
European Medicines Agency. 2012. Assessment report for Non-Steroidal
Anti-Inflammatory Drugs (NSAIDs) and cardiovascular risk
Gurbel, P.A., Becker, R.C., Mann, K.G., Steinhubl, S.R., Michelson, A.D.
2007. Platelet function monitoring in patients with coronary artery
disease.JACC.50(19):1822-1834
Haaspaniemmi, E., Soinne, I., Syrjala, M., Kaste, M., Tatlisumak,
T.2004.Serial changes in fibrinolysis and coagulation activation
markers in acute and convalesent phase of ischemic stroke.Acta
Neurologica Scandinavica.110:242-247
Halawani, S.H.M., Williams, D.J.P., Webster, J., Greaves, M., Ford, I.
2011. Aspirin failure in patients presenting with acute
cerebrovascular ischaemia. Thromb Haemost.106:240-247
Hee, F.L.L.S., Blann, A.D., Lip, G.Y.H. 2000. Effects of fixed low-dose
Warfarin. Aspirin-Warfarin Combination Therapy. dose adjusted
warfarin
on
thrombogenesis
in
chronic
atrial
fibrillation.Stroke.31:828-833
He, F., Xia, C., Zhang, H.J., Li, Q.X., Zhou, H.Z., Li, F.P., Li, W., et al.
2015. Clopidogrel plus aspirin versus aspirin alone for preventing
early neurological deterioration in patients with acute ischemic
stroke. Journal of Clinical Neuroscience.22:83-86
Heemskerk, J.W.M., Bevers, E.M., Lindhout, T . 2002. Platelet activation
and blood coagulation.Thromb Haemost.88:186-193
Jauch, E.C., Saver, J.L., Adams, H.P., Bruno, A., Connors, J.J.,
Demaerschalk, B.M., et al. 2013. Guidelines for the early
management of patients with acute ischemic stroke: A Guideline for
healthcare
professionals
from
the
American
Heart
Association/American Stroke Association.Stroke.44:870-947
Jennings, K. 2009. Mechanism of platelet activation: Need for new
strategies
to
protect
against
platelet-mediated
atherothrombosis.Thromb Haemost.102 : 248-257
Johns, C.S. 2004. Platelet Function Testing. Clinical Hemostasis Review.
Esoterix.18(4):1-9
Kamath, S., Blann, A.D., Chin, B.S.P., Lip, G.G.Y.H. 2002. A prospective
randomized trial of aspirin-clopidogrel combination therapy and
dose-adjusted warfarin on indices of thrombogenesis and platelet
activation in atrial fibrillation.J Am Coll Cardiol.40:484-490
Kamath, S., Blann, A.D., Lip, G.Y.H. 2001. Platelet activation: asessment
and quantification.European Heart Journal.22:1561-1571
Katzung, B.G., Masters, S.B., Trevor, A.J. 2011. Basic and Clinical
Pharmacology 12th Ed. McGraw Hill. San Fransisco
Lambrakis, P., Rushworth, G.F., Adamson, J., Leslie, S.J. 2011. Aspirin
hypersensitivity and desensitization protocols:implications for
cardiac patients.Ther Adv Drug Saf.2(6):263-270
Lee, Y.W., Cho, Y.H., Kkim, Y.H., Na, J.S., Shin, H.B., Ki,C.K.,et
al.2008.Aspirin non-responsiveness in koren subjects on dual
antiplatelet treatment determined by two different platelet function
assays.Annals of Clinical and Laboratory Science.38(2):126-131
Maree, A.O., Fitzgerald, D.J. 2007. Variable platelet response to aspirin
and clopidogrel in atherothrombotic.Circulation.115:2196-2207
Medhi, B.2008.Analgesic-Antipyretic and anti-inflammatory drug In : Seth,
S.D. and Seth, V (Ed).Textbook of pharmacology 3rd
Ed.Elsevier.India.37-38
Mehmetoglu, I. dan Kurban, S. 2012. Effects of two different dose of
acetylsalicylic aid on serum nitric oxide. asymmetric
dimethylarginine. and homocystein levels in healthy volunteers.Turk
J Med Sci.42(2):269-274
Meyer, D.M., Albright, K.C., Allison, T.A., Grotta, J.C. 2008. LOAD:a pilot
study of the safety of loading of aspirin and clopidogrel in acute
ischemic stroke and transient ischemic attack.J Stroke Cerebrovasc
Dis.17(1):26-29
Milan, M. .2007. Increased Body Iron Stores Are Asociated With Poor
Outcome After Trombolytic Treatment in Acute Stroke.Stroke.38:9095
Misbach, J. Dan Soertidewi, L.2011. Epidemiologi Stroke.Dalam: Misbach,
J., Soertidewi, L., Jannis, J., Bustami, M., Rasyid, A., Lumempauw,
S.F., dkk (Ed). Stroke. Aspek Diagnostik. Patofisiologi, Manajemen.
Badan Penerbit FKUI. Jakarta.1-10
Moghadam, S.F., Htun, P., Tormandi, B., Sander, D., Stellos, K., Geisler,
T., et al. 2007. Hyperresponsiveness of platelets in ischemic stroke.
Thromb Haemost.97:974-978
Montagnana, M., Salvagno,G.L., Lippi, G.2009.Circadian variation within
hemostasis: An underrecognized link between biology and
disease?.Semin Thromb Hemost.35(1):23-33
Navarro, V.J., Senior, J.R., 2006.The role of cholesterol and statins in
stroke.Current Cardiology Reports.11:4-11
Onoda, K., Ohashi, K., Hashimoto, A., Okuda, M., Shimono, T., Nishikawa,
M.,et al. 2008.Inhibition of platelet aggregation by combined therapy
with aspirin and cilostazol after off-pump coronary artery bypass
surgery. Ann Thoracic Cardiovasc Surg.14:230-237
Orynchak, M.A., Vasylechko, M.M. 2014. Status of Coagulation and
Platelet Hemostasis Parameters in Patients with Permanent Atrial
Fibrillation on the Background of Metabolic Syndrome.The Pharma
Innovation Journal; 2(11)
Park, Y.W., Koh, E.J., Choi, H.Y. 2011. Correlation between serum ddimer level and volume in acute iischemic stroke.J Korean
Neurosurg Soc.50:89-94
Patrono, C., Andreotti, F., Arnesen, H., Badimon, L., Baigent, C., Collet,
J.P., et al. 2011. Antiplatelet agents for the treatment and
prevention of atherothrombosis.European Heart Journal.32:29222932
Pawar, D., Maroli, A., Shahani, S. 1998. Aspirin-The novel antiplatelet
drug. HKMJ (4): 415-418
Perneby, C., Wallen, N.H., Rooney, C., Fitzgerald, D., Hjemdahl. 2006.
Dose and time dependent antiplatelet effects of aspirin. Thromb
Haemost.95:652-658
Pulcinelli, F.M., Pignatelli, P., Celestini, A., Riondino, S., Gazzaniga, P.P.,
Violi, F. 2004. Inhibiton of platelet aggregation by aspirin
progressively decreases in long term treated patients. J Am Coll
Cardiol. 43:979-984
Rist, P.M., Buring, J.E., Kase, C.S., Kurth, T. 2012. Efffect of low dose
aspirin on functional outcome from cerebral vascular events in
women. Stroke.44(2):432-436
Ritter, J.M., Lewis, L.D., Mant, T.G., Ferro, A. 2008. A Texbook of Clinical
Pharmacology and Therapeutics. 5th Ed. Hodder Arnol. London
Sacco, R.L. dan Elkind, M.S.,2000. Update on antiplateletet therapy for
stroke prevention.Arch Intern Med.60:1570-1582
Sacco, R.L., Kasner, S.E., Broderick, J.P., Caplan, L.R., Connors, J.J.,
Culebras, A., et al. 2013. An Updated Definition of Stroke for the
21st Century: A Statement for Healthcare Professionals From the
American Heart Association/American Stroke Association.
Stroke.44:2064-2089
Sjahrir, H. 2003. Stroke Iskemik. Yandira Agung. Medan.
Smith,
N.M., Pathansali, R., Bath, P.M.W.
stroke.Vascular Medicine.4:165-172
1999.
Platelets and
Tselepis, A.D., Gerotziafas, G., Andrikopoulos, G., Anninos, H., Vardas, P.
2011. Mechanisms of platelet activation and modification of
response to antiplatelet agents.Hellenic J Cardiol.52:128-140
Undas, A., Brummel-Ziedins, K.E., Mann, K.G. 2006. Antithrombotic
properties of aspirin and resistence to aspirin: beyond strictly
antiplatelet actions. Blood.109(6):2285-2292
Wakai, A., Gleeson, A., Winter, D. 2003. Role of fibrin D-dimer testing in
emergency medicine.Emerg Med J.20 :319-325
Wirawan, R. 2007. Nilai rujukan pemeriksaan agregasi trombosit dengan
adenosis difosfat pada orang indonesia dewasa normal di
Jakarta.Maj Kedokt Indon.57():212-219
Wilterdink, J.L., Bendixen, B., Adams, H.P., Woolson, R.F., Clarke, W.R.,
Hansen, M.D. 2001. Effect of prior aspirin use on stroke severity in
the Trial of ORG 10172 in Acute Stroke Treatment (TOAST).Stroke.
32:2836–2840
Woltz, M., Gouya, G., Kaplotis, S., Mueck, W., Kubitza, D. 2013. Openlabel. randomized study of the effect of rivaroxaban with or without
acetylsalicylic acid on thrombus formation in a perfusion
chamber.Thromb Res.132(2):240-247
Woodward, K., Lowe, G.D.O., Francis, L.M.A., Rumley, A., Cobbes, S.M.
2004. A randomized comparison of the effects of aspirin and
clopidogrel on thrombotic risk factors and C-reactive protein
following myocardial infarction: the CADET trial.Journal of
thrombosis and haemostasis.2:1934-1940
Wongkornrat, W., Sriyoscharti, S., Laksanabunsong, P., Phanchaipetch,
T., Subtaweesin, T., Thongchareun, P., et al. 2011. Comparison of
intensity of platelet aggregation between patients receiving low and
high aspirin dosage in post CABG patients.Siriraj Med J.63:187-190
Zhou, L. dan Schmaier, M.D.2005.Platelet aggregation testing in platelet
rich plasma : Description of procedures with the aim to develop
standards in the field.Am J Clin Pathol.123:172-183
Allen, L.M., Hasso, A.N., Handwerker, J., Fsrid, H. 2012. Sequencespesific MR Imaging Findings That Are Useful in Dating Ischemic
Stroke. Radiographics.32:1285-1297
An, G.H., Sim, S.Y., Jwa, C.S., Kim, G.H., Lee, J.Y., Kang, J.K. 2011.
Thromboxan A2 sinthetase inhibitor plus low dose aspirin : can it be
a salvage treatment in acute stroke beyond thrombolytic time
window.JJ Korean Neurosurg.50:1-2
Antiplatelet Trialists’ Collaboration. 2002. Collaborative overview of
randomised trials of antiplatelet therapy-I: prevention of death.
myocardial infarction. and stroke by prolonged antiplatelet therapy
in various categories of patients.BMJ.324:71–86
Arazi, H.C., Carnevalini, M., Falconi, E., Ovejero, R., Giorgi, M., Caroli, C.,
et al. 2012. The association of antiplateet aggregation effect of
aspirin and platelet count. Possible dosage implications.Rev Argent
Cardiol.80:114-120
Aydinalp, A., Atar, I., Altin, C., Gulmez, O., Atar, A., Acikel, S., et al. 2010.
Platelet function analysis with two different doses of aspirin. Ark
Turk Soc Cardiol.38(4):239-243
Bellomo, R., Ronco, C., Kellum, J.A., Mehta, R.L.,Palevsky, P.2004.Acute
renal failure-definition, outcome measures, animal models, fluid
therapy and information technology needs: the Second International
Consensus Confrence of the acute dialysis quality initiative (ADQI)
group. Crit Care.8(4)::204-212
Barber, M., Langhorne, P., Rumley, A., Lowe, G.D.O., Stott, D. 2006. DDimer Predicts Early Clinical Progression in Ischemic
Stroke.Stroke.37:1113-1115
Brass, L. 2010. Understanding and evaluating platelet function.American
Society of Hematology: 387-396
Cassar, K., Bachoo, P., Ford, I., Greaves, M., Brittenden, J. 2005.
Clopidogrel has no effect on D-dimer and thrombin-antithrombin III
levels in patients with peripheral arterial disease undergoing
peripheral percutaneous transluminal angioplasty. J Vasc
Surg.42:252-258
Chylova, M., Mot’ovska, Z., Osmancik, P., Prochazka, B., Kalvach, P.
2014. The effect of different doses and different routes of
acetylsalicylic acid administration on platelet aggregation in
healthy volunteers and ischemic stroke patients.Transl.Stroke
Res.6:160-165
Dahlan, M.S.2010. Besar sampel dan cara pengambilsan sampel dalam
penelitian kesehatan.Salemba Medika.Jakarta.Hal.46-60
Danesh, J., Whincup, P., Walker, M., Lennon, L., Thomson, A., Appleby,
P., et al. 2001. Fibrin D-dimer and coronary heart
disease.Circulation.103:2323-2327
DiChiara, J., Bliden, K.P., Tantry, U.S., Hamed, M.S., Antonino, M.J.,
Suarez, T.A., et al. 2007. The effect of aspirin dosing on platelet
function in diabetic and nondiabetic patients: An analysis from the
aspirin-induced platelet effect (ASPECT) Study.Diabetes.56:30143019
European Medicines Agency. 2012. Assessment report for Non-Steroidal
Anti-Inflammatory Drugs (NSAIDs) and cardiovascular risk
Gurbel, P.A., Becker, R.C., Mann, K.G., Steinhubl, S.R., Michelson, A.D.
2007. Platelet function monitoring in patients with coronary artery
disease.JACC.50(19):1822-1834
Haaspaniemmi, E., Soinne, I., Syrjala, M., Kaste, M., Tatlisumak,
T.2004.Serial changes in fibrinolysis and coagulation activation
markers in acute and convalesent phase of ischemic stroke.Acta
Neurologica Scandinavica.110:242-247
Halawani, S.H.M., Williams, D.J.P., Webster, J., Greaves, M., Ford, I.
2011. Aspirin failure in patients presenting with acute
cerebrovascular ischaemia. Thromb Haemost.106:240-247
Hee, F.L.L.S., Blann, A.D., Lip, G.Y.H. 2000. Effects of fixed low-dose
Warfarin. Aspirin-Warfarin Combination Therapy. dose adjusted
warfarin
on
thrombogenesis
in
chronic
atrial
fibrillation.Stroke.31:828-833
He, F., Xia, C., Zhang, H.J., Li, Q.X., Zhou, H.Z., Li, F.P., Li, W., et al.
2015. Clopidogrel plus aspirin versus aspirin alone for preventing
early neurological deterioration in patients with acute ischemic
stroke. Journal of Clinical Neuroscience.22:83-86
Heemskerk, J.W.M., Bevers, E.M., Lindhout, T . 2002. Platelet activation
and blood coagulation.Thromb Haemost.88:186-193
Jauch, E.C., Saver, J.L., Adams, H.P., Bruno, A., Connors, J.J.,
Demaerschalk, B.M., et al. 2013. Guidelines for the early
management of patients with acute ischemic stroke: A Guideline for
healthcare
professionals
from
the
American
Heart
Association/American Stroke Association.Stroke.44:870-947
Jennings, K. 2009. Mechanism of platelet activation: Need for new
strategies
to
protect
against
platelet-mediated
atherothrombosis.Thromb Haemost.102 : 248-257
Johns, C.S. 2004. Platelet Function Testing. Clinical Hemostasis Review.
Esoterix.18(4):1-9
Kamath, S., Blann, A.D., Chin, B.S.P., Lip, G.G.Y.H. 2002. A prospective
randomized trial of aspirin-clopidogrel combination therapy and
dose-adjusted warfarin on indices of thrombogenesis and platelet
activation in atrial fibrillation.J Am Coll Cardiol.40:484-490
Kamath, S., Blann, A.D., Lip, G.Y.H. 2001. Platelet activation: asessment
and quantification.European Heart Journal.22:1561-1571
Katzung, B.G., Masters, S.B., Trevor, A.J. 2011. Basic and Clinical
Pharmacology 12th Ed. McGraw Hill. San Fransisco
Lambrakis, P., Rushworth, G.F., Adamson, J., Leslie, S.J. 2011. Aspirin
hypersensitivity and desensitization protocols:implications for
cardiac patients.Ther Adv Drug Saf.2(6):263-270
Lee, Y.W., Cho, Y.H., Kkim, Y.H., Na, J.S., Shin, H.B., Ki,C.K.,et
al.2008.Aspirin non-responsiveness in koren subjects on dual
antiplatelet treatment determined by two different platelet function
assays.Annals of Clinical and Laboratory Science.38(2):126-131
Maree, A.O., Fitzgerald, D.J. 2007. Variable platelet response to aspirin
and clopidogrel in atherothrombotic.Circulation.115:2196-2207
Medhi, B.2008.Analgesic-Antipyretic and anti-inflammatory drug In : Seth,
S.D. and Seth, V (Ed).Textbook of pharmacology 3rd
Ed.Elsevier.India.37-38
Mehmetoglu, I. dan Kurban, S. 2012. Effects of two different dose of
acetylsalicylic aid on serum nitric oxide. asymmetric
dimethylarginine. and homocystein levels in healthy volunteers.Turk
J Med Sci.42(2):269-274
Meyer, D.M., Albright, K.C., Allison, T.A., Grotta, J.C. 2008. LOAD:a pilot
study of the safety of loading of aspirin and clopidogrel in acute
ischemic stroke and transient ischemic attack.J Stroke Cerebrovasc
Dis.17(1):26-29
Milan, M. .2007. Increased Body Iron Stores Are Asociated With Poor
Outcome After Trombolytic Treatment in Acute Stroke.Stroke.38:9095
Misbach, J. Dan Soertidewi, L.2011. Epidemiologi Stroke.Dalam: Misbach,
J., Soertidewi, L., Jannis, J., Bustami, M., Rasyid, A., Lumempauw,
S.F., dkk (Ed). Stroke. Aspek Diagnostik. Patofisiologi, Manajemen.
Badan Penerbit FKUI. Jakarta.1-10
Moghadam, S.F., Htun, P., Tormandi, B., Sander, D., Stellos, K., Geisler,
T., et al. 2007. Hyperresponsiveness of platelets in ischemic stroke.
Thromb Haemost.97:974-978
Montagnana, M., Salvagno,G.L., Lippi, G.2009.Circadian variation within
hemostasis: An underrecognized link between biology and
disease?.Semin Thromb Hemost.35(1):23-33
Navarro, V.J., Senior, J.R., 2006.The role of cholesterol and statins in
stroke.Current Cardiology Reports.11:4-11
Onoda, K., Ohashi, K., Hashimoto, A., Okuda, M., Shimono, T., Nishikawa,
M.,et al. 2008.Inhibition of platelet aggregation by combined therapy
with aspirin and cilostazol after off-pump coronary artery bypass
surgery. Ann Thoracic Cardiovasc Surg.14:230-237
Orynchak, M.A., Vasylechko, M.M. 2014. Status of Coagulation and
Platelet Hemostasis Parameters in Patients with Permanent Atrial
Fibrillation on the Background of Metabolic Syndrome.The Pharma
Innovation Journal; 2(11)
Park, Y.W., Koh, E.J., Choi, H.Y. 2011. Correlation between serum ddimer level and volume in acute iischemic stroke.J Korean
Neurosurg Soc.50:89-94
Patrono, C., Andreotti, F., Arnesen, H., Badimon, L., Baigent, C., Collet,
J.P., et al. 2011. Antiplatelet agents for the treatment and
prevention of atherothrombosis.European Heart Journal.32:29222932
Pawar, D., Maroli, A., Shahani, S. 1998. Aspirin-The novel antiplatelet
drug. HKMJ (4): 415-418
Perneby, C., Wallen, N.H., Rooney, C., Fitzgerald, D., Hjemdahl. 2006.
Dose and time dependent antiplatelet effects of aspirin. Thromb
Haemost.95:652-658
Pulcinelli, F.M., Pignatelli, P., Celestini, A., Riondino, S., Gazzaniga, P.P.,
Violi, F. 2004. Inhibiton of platelet aggregation by aspirin
progressively decreases in long term treated patients. J Am Coll
Cardiol. 43:979-984
Rist, P.M., Buring, J.E., Kase, C.S., Kurth, T. 2012. Efffect of low dose
aspirin on functional outcome from cerebral vascular events in
women. Stroke.44(2):432-436
Ritter, J.M., Lewis, L.D., Mant, T.G., Ferro, A. 2008. A Texbook of Clinical
Pharmacology and Therapeutics. 5th Ed. Hodder Arnol. London
Sacco, R.L. dan Elkind, M.S.,2000. Update on antiplateletet therapy for
stroke prevention.Arch Intern Med.60:1570-1582
Sacco, R.L., Kasner, S.E., Broderick, J.P., Caplan, L.R., Connors, J.J.,
Culebras, A., et al. 2013. An Updated Definition of Stroke for the
21st Century: A Statement for Healthcare Professionals From the
American Heart Association/American Stroke Association.
Stroke.44:2064-2089
Sjahrir, H. 2003. Stroke Iskemik. Yandira Agung. Medan.
Smith,
N.M., Pathansali, R., Bath, P.M.W.
stroke.Vascular Medicine.4:165-172
1999.
Platelets and
Tselepis, A.D., Gerotziafas, G., Andrikopoulos, G., Anninos, H., Vardas, P.
2011. Mechanisms of platelet activation and modification of
response to antiplatelet agents.Hellenic J Cardiol.52:128-140
Undas, A., Brummel-Ziedins, K.E., Mann, K.G. 2006. Antithrombotic
properties of aspirin and resistence to aspirin: beyond strictly
antiplatelet actions. Blood.109(6):2285-2292
Wakai, A., Gleeson, A., Winter, D. 2003. Role of fibrin D-dimer testing in
emergency medicine.Emerg Med J.20 :319-325
Wirawan, R. 2007. Nilai rujukan pemeriksaan agregasi trombosit dengan
adenosis difosfat pada orang indonesia dewasa normal di
Jakarta.Maj Kedokt Indon.57():212-219
Wilterdink, J.L., Bendixen, B., Adams, H.P., Woolson, R.F., Clarke, W.R.,
Hansen, M.D. 2001. Effect of prior aspirin use on stroke severity in
the Trial of ORG 10172 in Acute Stroke Treatment (TOAST).Stroke.
32:2836–2840
Woltz, M., Gouya, G., Kaplotis, S., Mueck, W., Kubitza, D. 2013. Openlabel. randomized study of the effect of rivaroxaban with or without
acetylsalicylic acid on thrombus formation in a perfusion
chamber.Thromb Res.132(2):240-247
Woodward, K., Lowe, G.D.O., Francis, L.M.A., Rumley, A., Cobbes, S.M.
2004. A randomized comparison of the effects of aspirin and
clopidogrel on thrombotic risk factors and C-reactive protein
following myocardial infarction: the CADET trial.Journal of
thrombosis and haemostasis.2:1934-1940
Wongkornrat, W., Sriyoscharti, S., Laksanabunsong, P., Phanchaipetch,
T., Subtaweesin, T., Thongchareun, P., et al. 2011. Comparison of
intensity of platelet aggregation between patients receiving low and
high aspirin dosage in post CABG patients.Siriraj Med J.63:187-190
Zhou, L. dan Schmaier, M.D.2005.Platelet aggregation testing in platelet
rich plasma : Description of procedures with the aim to develop
standards in the field.Am J Clin Pathol.123:172-183